← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AM REGENT · Approved 2017-05-12

Drug application

FDA Application #

ANDA204378

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

Oxaliplatin

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

AM REGENT

First approval

2017-05-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown